Boothbay Fund Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $973K | Buy |
141,378
+81,845
| +137% | +$563K | 0.02% | 530 |
|
|
2025
Q1 | $171K | Hold |
59,533
| – | – | ﹤0.01% | 1024 |
|
|
2024
Q4 | $280K | Buy |
59,533
+37,596
| +171% | +$177K | 0.01% | 935 |
|
|
2024
Q3 | $78.3K | Buy |
+21,937
| New | +$78.3K | ﹤0.01% | 1281 |
|
|
2024
Q1 | – | Sell |
-11,730
| Closed | -$79.2K | – | 1508 |
|
|
2023
Q4 | $79.2K | Buy |
+11,730
| New | +$79.2K | ﹤0.01% | 1289 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2048 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2082 |
|
|
2021
Q3 | – | Sell |
-29,050
| Closed | -$304K | – | 1752 |
|
|
2021
Q2 | $304K | Sell |
29,050
-21,834
| -43% | -$228K | 0.01% | 1119 |
|
|
2021
Q1 | $599K | Buy |
50,884
+976
| +2% | +$11.5K | 0.02% | 687 |
|
|
2020
Q4 | $584K | Buy |
+49,908
| New | +$584K | 0.02% | 566 |
|